Client Wins From November 27
Patheon Successfully Deploys Compuware Changepoint for Professional Services Automation: Compuware Corp. (Nasdaq:CPWR) announced Tuesday that the Durham, N.C. contract drug developer and manufacturer Patheon Inc. has successfully deployed Changepoint’s professional services automation solution to manage the firm’s 700-employee pharmaceutical development services (PDS) organization. Employing approximately 4,000 highly skilled staff, Patheon is a leading global provider of contract drug development and manufacturing services to the pharmaceutical industry. The company’s PDS group, where Changepoint has been deployed, offers contract pre-formulation, formulation and analytical development, clinical trial materials manufacturing, clinical packaging and scale-up services for pharmaceutical products of essentially all types, including biopharmaceuticals. Patheon enjoys the top share position in the markets it serves, but in an increasingly competitive market the company faces the challenge of maintaining strong revenue growth and profitability. To strengthen core operations, the company has put in place a strategy to drive efficiency improvements throughout its facilities, materials and supporting operations. To realize this business strategy and achieve its goals for the PDS division, the company recognized a need to invest in a broader solution for project delivery. Compuware Changepoint allows technology companies to maximize professional services profitability while maintaining a focus on effective product decisions and delivery. Changepoint’s integrated solution marries PSA with PPM to provide total operational visibility allowing product-centric technology companies to drive services growth with strong margins, deliver a competitive product and services mix for high ROI, and maintain top-line revenues and bottom-line profitability. Changepoint is available via SaaS or On-Premise Delivery Model. Visit us http://www.compuware.com/changepoint or tune into our blog at http://www.changepoint-blog.net.